1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Haemophilia Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Haemophilia Market - Industry Life Cycle |
3.4 United Kingdom (UK) Haemophilia Market - Porter's Five Forces |
3.5 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Treatment, 2022 & 2032F |
3.6 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Diagnosis, 2022 & 2032F |
3.8 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Patient, 2022 & 2032F |
3.9 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.10 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.11 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United Kingdom (UK) Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in treatment options for haemophilia |
4.2.2 Increasing awareness and diagnosis rates of haemophilia in the UK |
4.2.3 Growing research and development activities in the field of haemophilia treatments |
4.3 Market Restraints |
4.3.1 High cost associated with haemophilia treatment and management |
4.3.2 Limited access to specialized healthcare services in certain regions of the UK |
4.3.3 Regulatory challenges and compliance requirements in the haemophilia market |
5 United Kingdom (UK) Haemophilia Market Trends |
6 United Kingdom (UK) Haemophilia Market, By Types |
6.1 United Kingdom (UK) Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Treatment, 2022-2032F |
6.1.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Medication, 2022-2032F |
6.1.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Desmopressin, 2022-2032F |
6.1.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Emicizumab, 2022-2032F |
6.1.6 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2022-2032F |
6.1.7 United Kingdom (UK) Haemophilia Market Revenues & Volume, By ITI Therapy, 2022-2032F |
6.1.8 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Gene Therapy, 2022-2032F |
6.1.9 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.2 United Kingdom (UK) Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Oral, 2022-2032F |
6.2.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Injectable, 2022-2032F |
6.2.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.3 United Kingdom (UK) Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Blood Test, 2022-2032F |
6.3.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Genetic Tests, 2022-2032F |
6.3.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.4 United Kingdom (UK) Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Pediatric, 2022-2032F |
6.4.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Adult, 2022-2032F |
6.5 United Kingdom (UK) Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia A, 2022-2032F |
6.5.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia B, 2022-2032F |
6.5.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia C, 2022-2032F |
6.5.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.6 United Kingdom (UK) Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospitals, 2022-2032F |
6.6.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Specialty Clinics, 2022-2032F |
6.6.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Homecare, 2022-2032F |
6.6.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.7 United Kingdom (UK) Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2022-2032F |
6.7.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2022-2032F |
6.7.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.7.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
7 United Kingdom (UK) Haemophilia Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Haemophilia Market Export to Major Countries |
7.2 United Kingdom (UK) Haemophilia Market Imports from Major Countries |
8 United Kingdom (UK) Haemophilia Market Key Performance Indicators |
8.1 Patient adherence and compliance rates to prescribed haemophilia treatment plans |
8.2 Number of clinical trials and research studies conducted in the field of haemophilia in the UK |
8.3 Rate of adoption of new haemophilia treatment technologies and therapies in the UK market |
9 United Kingdom (UK) Haemophilia Market - Opportunity Assessment |
9.1 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Treatment, 2022 & 2032F |
9.2 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Diagnosis, 2022 & 2032F |
9.4 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Patient, 2022 & 2032F |
9.5 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Type, 2022 & 2032F |
9.6 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.7 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United Kingdom (UK) Haemophilia Market - Competitive Landscape |
10.1 United Kingdom (UK) Haemophilia Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |